These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response. Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409 [TBL] [Abstract][Full Text] [Related]
3. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Picard E; Verschoor CP; Ma GW; Pawelec G Front Immunol; 2020; 11():369. PubMed ID: 32210966 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability. Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503 [TBL] [Abstract][Full Text] [Related]
5. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687 [TBL] [Abstract][Full Text] [Related]
6. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment. Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431 [TBL] [Abstract][Full Text] [Related]
7. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape. Glaire MA; Ryan NA; Ijsselsteijn ME; Kedzierska K; Obolenski S; Ali R; Crosbie EJ; Bosse T; de Miranda NF; Church DN J Pathol; 2022 Jul; 257(3):340-351. PubMed ID: 35262923 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer. Lin A; Zhang J; Luo P Front Immunol; 2020; 11():2039. PubMed ID: 32903444 [TBL] [Abstract][Full Text] [Related]
9. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. Mlecnik B; Bindea G; Angell HK; Maby P; Angelova M; Tougeron D; Church SE; Lafontaine L; Fischer M; Fredriksen T; Sasso M; Bilocq AM; Kirilovsky A; Obenauf AC; Hamieh M; Berger A; Bruneval P; Tuech JJ; Sabourin JC; Le Pessot F; Mauillon J; Rafii A; Laurent-Puig P; Speicher MR; Trajanoski Z; Michel P; Sesboüe R; Frebourg T; Pagès F; Valge-Archer V; Latouche JB; Galon J Immunity; 2016 Mar; 44(3):698-711. PubMed ID: 26982367 [TBL] [Abstract][Full Text] [Related]
10. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters. Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871 [No Abstract] [Full Text] [Related]
11. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer. Greco L; Rubbino F; Dal Buono A; Laghi L Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349 [TBL] [Abstract][Full Text] [Related]
12. Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer. Inamori K; Togashi Y; Fukuoka S; Akagi K; Ogasawara K; Irie T; Motooka D; Kobayashi Y; Sugiyama D; Kojima M; Shiiya N; Nakamura S; Maruyama S; Suzuki Y; Ito M; Nishikawa H JCI Insight; 2021 May; 6(9):. PubMed ID: 33755600 [TBL] [Abstract][Full Text] [Related]
13. Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers. Kim JH; Seo MK; Lee JA; Yoo SY; Oh HJ; Kang H; Cho NY; Bae JM; Kang GH; Kim S J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903553 [TBL] [Abstract][Full Text] [Related]
14. The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. Marisa L; Svrcek M; Collura A; Becht E; Cervera P; Wanherdrick K; Buhard O; Goloudina A; Jonchère V; Selves J; Milano G; Guenot D; Cohen R; Colas C; Laurent-Puig P; Olschwang S; Lefèvre JH; Parc Y; Boige V; Lepage C; André T; Fléjou JF; Dérangère V; Ghiringhelli F; de Reynies A; Duval A J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922790 [TBL] [Abstract][Full Text] [Related]
15. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts. Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574 [TBL] [Abstract][Full Text] [Related]
16. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779 [TBL] [Abstract][Full Text] [Related]
17. Mismatch repair status in sporadic colorectal cancer: immunohistochemistry and microsatellite instability analyses. Yoon YS; Yu CS; Kim TW; Kim JH; Jang SJ; Cho DH; Roh SA; Kim JC J Gastroenterol Hepatol; 2011 Dec; 26(12):1733-9. PubMed ID: 21615788 [TBL] [Abstract][Full Text] [Related]
19. Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers. Sato K; Kawazu M; Yamamoto Y; Ueno T; Kojima S; Nagae G; Abe H; Soda M; Oga T; Kohsaka S; Sai E; Yamashita Y; Iinuma H; Fukayama M; Aburatani H; Watanabe T; Mano H Clin Cancer Res; 2019 Jan; 25(1):378-389. PubMed ID: 30279230 [TBL] [Abstract][Full Text] [Related]
20. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience. Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]